1. Considering the value associated with innovation in health technology appraisal decisions (deliberations)

   • Colin Green

   Editorial 06 August 2012 Pages: 1 - 5

2. Ongoing pharmaceutical reforms in France

   • Catherine Sermet
   • Veronique Andrieu
   • Jean-Pierre Reynier

   Current Opinion 06 August 2012 Pages: 7 - 24

   

3. Is the societal approach wide enough to include relatives?

   • Thomas Davidson
   • Lars-Åke Levin

   Leading Article 06 August 2012 Pages: 25 - 35

   

4. Analytical strategies for characterizing chemotherapy diffusion with patient-level population-based data

   • Cami S. Sima
   • Katherine S. Panageas
   • Deborah Schrag

   Practical Application 06 August 2012 Pages: 37 - 51

   

5. Inpatient costs of endophthalmitis evaluated for the whole of France

   • Xavier Colin
   • Gilles Berdeaux
   • Laurent Kodjikian

   Original Research Article 06 August 2012 Pages: 53 - 60

   

6. Healthcare costs in renal transplant recipients using branded versus generic ciclosporin

   • J. Harold Helderman
   • Ning Kang
   • Judy Y. Chen

   Original Research Article 06 August 2012 Pages: 61 - 68

   

7. Oral therapies for the treatment of pulmonary arterial hypertension: a population-based cost-minimization analysis

   • Marie-Claude Lefebvre
   • Elke Hunsche

   Correspondence 06 August 2012 Pages: 69 - 71

8. The authors’ reply

   • George Dranitsaris
   • Sanjay Mehta

   Correspondence 06 August 2012 Pages: 71 - 73